Oncologic Procedures Amenable to Fluorescence-guided Surgery
Kiranya E. Tipirneni(University of Alabama at Birmingham), Eben L. Rosenthal(Vanderbilt University Medical Center), Alexander L. Vahrmeijer(Leiden University Medical Center), Kurt R. Zinn(University of Alabama at Birmingham), Lindsay S. Moore(University of Alabama at Birmingham), George A. Poultsides(Stanford University), William R. Carroll(University of Alabama at Birmingham), Esther de Boer(University Medical Center Groningen), Mary T. Hawn(Stanford University), Irene Wapnir(Stanford Medicine), Jason M. Warram(University of Alabama at Birmingham), Andrew C. Prince(University of Alabama at Birmingham), Joseph C. Liao(VA Palo Alto Health Care System), Aditi Jani(University of Alabama at Birmingham), Nicole K. Behnke(University of Alabama at Birmingham), Michael Bouvet(University of California San Diego Medical Center)
Cited by 155
Related Papers
Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function
|The Journal of Immunology|2006|487
Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer
|Clinical Cancer Research|2015|477
Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial Treatment
|Journal of Clinical Oncology|2009|390
Fundamentals and developments in fluorescence-guided cancer surgery
|Nature Reviews Clinical Oncology|2021|371